Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Norwegian Hydrogen Specialist Faces Mounting Pressure as Analyst Cuts Target

Dieter Jaworski by Dieter Jaworski
October 1, 2025
in Analysis, European Markets, Hydrogen
0
Nel ASA Stock
0
SHARES
94
VIEWS
Share on FacebookShare on Twitter

The Norwegian hydrogen company Nel ASA finds itself navigating increasingly turbulent waters as another blow strikes its already beleaguered stock. A significant price target reduction from the financial firm Jefferies has compounded the negative sentiment following a severe sell-off earlier in the week.

A Deepening Downtrend

Investors in Nel have witnessed a prolonged and painful decline. The stock’s value has eroded by more than 55 percent over the last twelve months, highlighting significant underlying challenges. This long-term performance paints a grim picture, characterized by extreme price volatility and a persistent downward trajectory that recent events have only intensified.

A Brutal Start to the Week

Trading on Monday delivered a devastating blow to shareholders, with Nel shares plunging 5.56 percent to rank among the session’s poorest performers. A marginal recovery was observed on Tuesday, with the stock edging up 0.47 percent to 2.15 Norwegian Krone. However, this slight uptick does little to counter the overwhelmingly negative technical chart pattern and overall market sentiment.

Should investors sell immediately? Or is it worth buying Nel ASA?

Jefferies Delivers a Sharp Downgrade

The situation worsened when analysts at Jefferies issued a stark revision. While the firm maintained its “Neutral” rating on Nel, it slashed its price target by a substantial 25 percent. The new target was lowered from 3.00 NOK to just 2.20 NOK. This revised forecast implies minimal potential for upward movement from the current trading level, signaling a markedly more pessimistic outlook on the hydrogen specialist’s future prospects.

The confluence of these factors creates a perfect storm for the company:
* A one-year performance showing a loss exceeding 55%
* Intense share price volatility and sharp swings
* A drastic price target cut from a major analyst firm, further weighing on investor morale

The evidence points to a stock firmly entrenched in a downtrend, with the minor Tuesday gain failing to alter the bearish overarching trend.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from March 25 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Glencore Stock
Analysis

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

March 25, 2026
Energiekontor Stock
Energy & Oil

Energiekontor Stock Gains Momentum from Policy Shifts

March 25, 2026
Ocugen Stock
Analysis

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
Next Post
Eutelsat Stock

Eutelsat Strengthens Arctic Presence with Strategic Greenland Partnership

XRP Stock

XRP Approaches Critical Juncture Amid ETF Speculation and Institutional Accumulation

Cardano Stock

Cardano at a Crossroads: Ecosystem Developments Clash With Market Pressure

Recommended

Finance_Cash

Important Information for Investors Dividend Distribution and Key Dates for First Commonwealth NYSE FCF Stock

2 years ago
iShares MSCI World ETF Stock

The Hidden Concentration Risk in Your Global ETF Portfolio

5 months ago
Assembly Biosciences Stock

Assembly Biosciences Shares Extend Losses Amid Heavy Selling Pressure

6 months ago

Raymond James Financial Services Advisors Inc. Decreases Holdings in Snap-on Incorporated: Examining Investment Strategy Shift and Analyst Perspectives

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Trending

Glencore Stock
Analysis

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

by Jackson Burston
March 25, 2026
0

While the broader copper market faces significant headwinds, shares in the diversified mining and trading giant Glencore...

Energiekontor Stock

Energiekontor Stock Gains Momentum from Policy Shifts

March 25, 2026
Bionxt Solutions Stock

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Glencore Shares Demonstrate Resilience Amid Copper Market Weakness
  • Energiekontor Stock Gains Momentum from Policy Shifts
  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com